An expert involved in the first successful gene therapy trial for Huntington's Disease discusses the trial results and ...
OCGN's gene-agnostic eye therapy aims to treat multiple retinal mutations, with key filings and pivotal data in 2026???2027 set to test its broad platform.
Chantez Sanford Jr., 24, of Southfield, says his life has been transformed after undergoing Lyfgenia gene therapy at Children ...
SINGAPORE, SG / ACCESS Newswire / March 20, 2026 / Immortal Dragons, a $40M longevity fund headquartered in Singapore, today announced that its portfolio company Unlimited Bio has registered a Phase 1 ...
He is the first person in the state to receive LYFGENIA, a one-time gene therapy designed to keep the red blood cells that ...
The last available hemophilia gene therapy is temporarily unavailable, according to CSL Behring. | The company is working ...
Nemours Children's Hospital is now offering Lyfgenia gene therapy. The treatment aims to reduce pain crises and hospital visits for young patients.
Zacks Investment Research on MSN
SRPT stock up as enrollment begins in DMD gene therapy safety study
Shares of Sarepta Therapeutics SRPT rose about 2% yesterday after it announced that screening and enrollment are underway in ...
While life-long oral treatment is subsidised by the government, one-off gene therapies are not. Read more at straitstimes.com ...
The search for gene therapies to treat rheumatoid arthritis (RA) has moved in fits and starts over the past two decades, with trials starting and stopping, and their focus shifting to osteoarthritis ...
Researchers at the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) have developed a ...
Forbes contributors publish independent expert analyses and insights. A patient in a late-stage gene editing trial for a rare heart condition died from fatal liver complications after receiving an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results